title: 5T4 as a target for immunotherapy in renal cell carcinoma.
authors: Eyad
authors: E
authors: Elkord
authors: Alaaeldin
authors: A
authors: Shablak
authors: Peter L
authors: PL
authors: Stern
authors: Robert E
authors: RE
authors: Hawkins
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D008562:Membrane Glycoproteins / Q000235:genetics* / Q000276:immunology; D019444:Vaccines, DNA
chemical_list: D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines; D008562:Membrane Glycoproteins; C504058:TroVax; D019444:Vaccines, DNA; C063709:trophoblastic glycoprotein 5T4, human